{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:58:13Z","timestamp":1775620693855,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11255-021-02857-z","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:15:50Z","timestamp":1619032550000},"page":"2333-2339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["FRAX scores are increased in patients with ANCA-associated vasculitis"],"prefix":"10.1007","volume":"53","author":[{"given":"Betul","family":"Cetin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin Ahmet","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakki","family":"Arikan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Velioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Alibaz-Oner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhan","family":"Tuglular","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-115X","authenticated-orcid":false,"given":"Ebru","family":"Asicioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"2857_CR1","unstructured":"Papadakis MA, McPhee SJ (2016) Current medical diagnosis and treatment, 55th edn. McGraw-Hill, New York, pp 923\u2013924"},{"key":"2857_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","volume":"75","author":"Geetha","year":"2020","unstructured":"Geetha et al (2020) ANCA associated vasculitis: core cirruculum. Am J Kidney Dis 75:124\u2013137","journal-title":"Am J Kidney Dis"},{"key":"2857_CR3","first-page":"37","volume":"32","author":"D Cornec","year":"2017","unstructured":"Cornec D, Cornec-Le Gall E, Specks U (2017) Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learned so far, and what we still have to learn. Nephrol Dial Transplant 32:37\u201347","journal-title":"Nephrol Dial Transplant"},{"key":"2857_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s40674-017-0082-y","volume":"3","author":"C King","year":"2017","unstructured":"King C, Harper L (2017) Avoidance of harm from treatment for ANCA-associated vasculitis. Curr Treatm Opt Rheumatol 3:230\u2013243","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"2857_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3810\/pgm.2010.01.2102","volume":"122","author":"ES Siris","year":"2010","unstructured":"Siris ES, Baim S, Nattiv A (2010) Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 122:82\u201390","journal-title":"Postgrad Med"},{"key":"2857_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bone.2013.05.002","volume":"56","author":"KH Rubin","year":"2013","unstructured":"Rubin KH, Abrahamsen B, Friis-Holmberg T, Hjelmborg JV, Bech M, Hermann AP, Barkmann R, Gl\u00fcer CC, Brixen K (2013) Comparison of different screening tools (FRAX\u00ae, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. Bone 56:16\u201322","journal-title":"Bone"},{"key":"2857_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s198-002-8341-z","volume":"13","author":"MM Boomsa","year":"2002","unstructured":"Boomsa MM, Stegeman CA, Kramer AB, Karsijns M, Piers DA, Tervaert JW (2002) Prevalance of reduced bone mineral density in patients with anti-neutrophil cytoplasmic antibody associated vasculitis and the role of \u0131mmunosuppresive therapy: a cross-sectional study. Osteoporosis Int 13:74\u201382","journal-title":"Osteoporosis Int"},{"key":"2857_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/14397595.2013.852836","volume":"24","author":"M Itabashi","year":"2014","unstructured":"Itabashi M, Takei T, Moriyama T, Shiohira S, Shimizu A, Tsuruta Y, Uchida K, Nitta K (2014) Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index. Mod Rheumatol 24:112\u2013119","journal-title":"Mod Rheumatol"},{"key":"2857_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","volume":"74","author":"J Robson","year":"2015","unstructured":"Robson J, Doll H, Suppiah R, Flossmann O, Harper L, H\u00f6glund P, Jayne D, Mahr A, Westman K, Luqmani R (2015) Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials. Ann Rheum Dis 74:177\u2013184","journal-title":"Ann Rheum Dis"},{"key":"2857_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10067-002-8274-7","volume":"21","author":"K Shibuya","year":"2002","unstructured":"Shibuya K, Hagino H, Morio Y, Teshima R (2002) Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 21:150\u2013158","journal-title":"Clin Rheumatol"},{"key":"2857_CR11","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1590\/S1807-59322010001100024","volume":"65","author":"RM Pereira","year":"2010","unstructured":"Pereira RM, Carvalho JF, Canalis E (2010) Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo) 65:1197\u20131205","journal-title":"Clinics (Sao Paulo)"},{"key":"2857_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, Jayne D, Harper L, European Vasculitis Study (EUVAS) Group (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036\u20131043","journal-title":"Ann Rheum Dis"},{"key":"2857_CR13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3899\/jrheum.141566","volume":"42","author":"M Faurschou","year":"2015","unstructured":"Faurschou M, Baslund B, Obel N (2015) Pronounced risk of fractures among elderly men affected by granulomatosis with polyangiitis. J Rheumatol 42:1667\u20131671","journal-title":"J Rheumatol"},{"key":"2857_CR14","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3899\/jrheum.151151","volume":"43","author":"M Englund","year":"2016","unstructured":"Englund M, Merkel PA, Tomasson G, Segelmark M, Mohammad AJ (2016) Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population. J Rheumatol 43:1553\u20131558","journal-title":"J Rheumatol"},{"key":"2857_CR15","unstructured":"T\u00fcz\u00fcn \u015e, Meray J, Peker \u00d6 (2012) Epidemiyoloji T\u00fcrkiye \u00c7al\u0131\u015fmas\u0131 Fracturk. Osteoporozda Tan\u0131 ve Tedavi. Galenos Publishing, Istanbul, pp 22\u201334"},{"key":"2857_CR16","first-page":"S1197","volume":"79","author":"M Rato","year":"2020","unstructured":"Rato M, Pinheiro F, Garcia S, Fernandes BM, Ganhao S, Gaio R, Bernardes M, Bernardo A, Costa L (2020) FRAX 10-yr fracture risk in rheumatoid arthritis assessed with and without bone mineral density\u2014are we treating our patients under bDMARDs? Ann Rheum Dis 79:S1197-1198","journal-title":"Ann Rheum Dis"},{"key":"2857_CR17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, Morrison L, Rao M, Byun Robinson A, Saha S, Wolver S, Bannuru RR, Vaysbrot E, Osani M, Turgunbaev M, Miller AS, McAlindon T (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 69:1521\u20131537","journal-title":"Arthritis Rheumatol"},{"key":"2857_CR18","doi-asserted-by":"publisher","first-page":"e6677","DOI":"10.1097\/MD.0000000000006677","volume":"96","author":"J Meng","year":"2017","unstructured":"Meng J, Li Y, Yuan X, Lu Y (2017) Evaluating osteoporotic fracture risk with the fracture risk assessment tool in Chinese patients with rheumatoid arthritis. Medicine (Baltimore) 96:e6677","journal-title":"Medicine (Baltimore)"},{"key":"2857_CR19","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s10067-018-4218-8","volume":"37","author":"R Phuan-Udom","year":"2018","unstructured":"Phuan-Udom R, Lektrakul N, Katchamart W (2018) The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis. Clin Rheumatol 37:2603\u20132610","journal-title":"Clin Rheumatol"},{"key":"2857_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13075-018-1515-1","volume":"20","author":"TT Cheng","year":"2018","unstructured":"Cheng TT, Yu SF, Su FM, Chen YC, Su BY, Chiu WC, Hsu CY, Chen JF, Ko CH, Lai HM (2018) Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX\u00ae: a registry study of RA with osteoporosis\/fracture. Arthritis Res Ther 20:16","journal-title":"Arthritis Res Ther"},{"key":"2857_CR21","doi-asserted-by":"publisher","first-page":"e5959","DOI":"10.1097\/MD.0000000000005959","volume":"96","author":"SF Yu","year":"2017","unstructured":"Yu SF, Chen JF, Chen YC, Lai HM, Ko CH, Chiu WC, Su FM, Hsu CY, Su BY, Wu CH, Cheng TT (2017) Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: a nationwide osteoporosis survey. Medicine (Baltimore) 96:e5959","journal-title":"Medicine (Baltimore)"},{"key":"2857_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00223-018-0401-9","volume":"102","author":"AM Dubrovsky","year":"2018","unstructured":"Dubrovsky AM, Lim MJ, Lane NE (2018) Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton. Calcif Tissue Int 102:607\u2013618","journal-title":"Calcif Tissue Int"},{"key":"2857_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP van Staa","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"2857_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG (2006) Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 55:420\u2013426","journal-title":"Arthritis Rheum"},{"key":"2857_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","volume":"39","author":"A Angeli","year":"2006","unstructured":"Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253\u2013259","journal-title":"Bone"},{"key":"2857_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jbmr.2017","volume":"29","author":"H Johansson","year":"2014","unstructured":"Johansson H, Kanis JA, Od\u00e9n A, McCloskey E, Chapurlat RD, Christiansen C, Cummings SR, Diez-Perez A, Eisman JA, Fujiwara S, Gl\u00fcer CC, Goltzman D, Hans D, Khaw KT, Krieg MA, Kr\u00f6ger H, LaCroix AZ, Lau E, Leslie WD, Mellstr\u00f6m D, Melton LJ 3rd, O\u2019Neill TW, Pasco JA, Prior JC, Reid DM, Rivadeneira F, van Staa T, Yoshimura N, Zillikens MC (2014) A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 29:223\u2013233","journal-title":"J Bone Miner Res"},{"key":"2857_CR27","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.10613","volume":"46","author":"DH Solomon","year":"2002","unstructured":"Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J (2002) Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 46:3136\u20133142","journal-title":"Arthritis Rheum"},{"key":"2857_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40620-017-0430-x","volume":"30","author":"P Lips","year":"2017","unstructured":"Lips P, Goldsmith D, de Jongh R (2017) Vitamin D and osteoporosis in chronic kidney disease. J Nephrol 30:671\u2013675","journal-title":"J Nephrol"},{"key":"2857_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92:26\u201336","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-02857-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02857-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T08:45:53Z","timestamp":1633596353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-02857-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-02857-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}